Impaired Autophagic Flux by Citalopram Inhibits DR5 Degradation and Increases TRAIL‐Mediated Apoptosis.Published in:Journal of Clinical Pharmacy & Therapeutics, 2025, v. 2025, p. 1, doi. 10.1155/jcpt/7538839By:Zinnah, K. M. A.;Munna, Ali Newaz;Seol, Jae-Won;Park, Sang-Youel;Jiao, PeirongPublication type:Article
Optimizing autophagy modulation for enhanced TRAIL‐mediated therapy: Unveiling the superiority of late‐stage inhibition over early‐stage inhibition to overcome therapy resistance in cancer.Published in:Basic & Clinical Pharmacology & Toxicology, 2025, v. 136, n. 1, p. 1, doi. 10.1111/bcpt.14110By:Zinnah, Kazi Mohammad Ali;Munna, Ali Newaz;Park, Sang‐YouelPublication type:Article